Reuters logo
BRIEF-Intrexon and Arch Pharmalabs collaborate on fermentative production of an API to replace existing process sourced from animals
October 23, 2017 / 12:28 PM / a month ago

BRIEF-Intrexon and Arch Pharmalabs collaborate on fermentative production of an API to replace existing process sourced from animals

Oct 23 (Reuters) - Arch Pharmalabs Ltd

* Intrexon and Arch Pharmalabs collaborate on fermentative production of an API to replace existing process sourced from animals

* Intrexon Corp - ‍Arch Pharmalabs will have exclusive access to co’s technologies for fermentation-based production of specific API

* Intrexon - Will receive technology access fee, milestone payments, as well as a 40% royalty based on gross profit of commercialized products Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below